Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Sorror
Mohamed L
ML
Leisenring
Wendy
W
Deeg
H Joachim
HJ
Martin
Paul J
PJ
Storb
Rainer
R
D016026:Bone Marrow Transplantation / Q000009:adverse effects; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D006650:Histocompatibility Testing; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use*; D011292:Premedication; D015995:Prevalence; D016019:Survival Analysis
D016572:Cyclosporine; D008727:Methotrexate